Express Scripts’s $2.5 Billion Registered Senior Debt Offering
June 05, 2014
Cravath represented the underwriters, led by Citigroup, Credit Suisse, Deutsche Bank Securities and RBS, in connection with the US$2.5 billion registered senior debt offering of Express Scripts Holding Company, the largest pharmacy benefit management company in the United States. The transaction closed on June 5, 2014.
The Cravath team included partner William J. Whelan III and associates Brendan R. Mahan and Cameron S. Stanton. Summer associate William A. Magioncalda also worked on this matter.
Related Practices & Industries
People
- Photo
-
-
J.D., 1983, Fordham University School of Lawcum laude
-
B.A., 1980, University of Virginiawith Distinction
Education
Related News & Insights
Deals & Cases
December 01, 2025
Polaris Inc.’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of Polaris Inc. Polaris Inc. designs, engineers, manufactures and markets powersport vehicles and also designs and manufactures or sources parts, garments and accessories. The transaction closed on November 13, 2025.
Deals & Cases
December 01, 2025
The Mosaic Company’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $900 million registered senior notes offering of The Mosaic Company, the world’s leading producer and marketer of concentrated phosphate and potash crop nutrients. The transaction closed on November 13, 2025.
Deals & Cases
November 26, 2025
Howmet Aerospace Inc.’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $500 million registered notes offering of Howmet Aerospace Inc., a leading global provider of advanced engineered solutions for the aerospace and transportation industries. The transaction closed on November 12, 2025.
Deals & Cases
November 18, 2025
Ripple Labs, Inc.’s Private Placement of Class A Common Stock
Cravath represented funds managed by affiliates of Brevan Howard in connection with an investment in Ripple Labs, Inc., consisting of a private placement of Class A Common Stock, as part of Ripple’s $500 million strategic investment at a $40 billion valuation, led by funds managed by affiliates of Fortress Investment Group, affiliates of Citadel Securities, Pantera Capital, Galaxy Digital, Brevan Howard and Marshall Wace. The transaction closed on November 4, 2025.
